Literature DB >> 22796533

Alloreactive effector T cells require the local formation of a proinflammatory environment to allow crosstalk and high avidity interaction with nonhematopoietic tissues to induce GVHD reactivity.

Boris van der Zouwen1, Alwine B Kruisselbrink, Ekaterina S Jordanova, Caroline E Rutten, Peter A von dem Borne, J H Frederik Falkenburg, Inge Jedema.   

Abstract

Based on clinical observations that donor T cells specific for minor histocompatibility antigens (MiHA) ubiquitously expressed on both hematopoietic and nonhematopoietic cells were detected in patients showing evident graft-versus-leukemia/lymphoma (GVL) reactivity with no or limited coinciding graft-versus-host disease (GVHD), we hypothesized that nonhematopoietic tissues may be relatively unsusceptible to the cytotoxic effect of MiHA-specific T cells under normal, noninflammatory conditions. To test this hypothesis, we investigated the reactivity of alloreactive T cells specific for ubiquitously expressed MiHA against skin-derived primary human fibroblasts. We demonstrated that this reactivity was not merely determined by their antigen-specificity, but was highly dependent on adhesion molecule expression. ICAM-1 expression on the fibroblasts upregulated under proinflammatory conditions and induced during cross-talk with the T cells was demonstrated to be a crucial factor facilitating formation of high avidity interactions with the T cells and subsequent efficient target cell destruction. Furthermore, we provide supporting evidence for the role of ICAM-1 in vivo by demonstrating that ICAM-1 expression on nonhematopoietic target cells was dependent on the presence of infiltrating activated T cells, as was illustrated by restricted ICAM-1 expression at the sites of T cell infiltration in skin biopsies of patients with acute GVHD (aGVHD), by the absence of ICAM-1 expression in the same biopsies in areas without T cell infiltration and by the absence of ICAM-1 expression in biopsies of patients without GVHD independent of the presence of infiltrating nonactivated T cells. In conclusion, under noninflammatory conditions, nonhematopoietic tissues are unsusceptible to the GVHD reactivity of alloreactive T cells due to their inability to establish high avidity interactions.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796533     DOI: 10.1016/j.bbmt.2012.06.017

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  6 in total

Review 1.  Graft versus tumor effects and why people relapse.

Authors:  J H Frederik Falkenburg; Inge Jedema
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 2.  Allo-reactive T cells for the treatment of hematological malignancies.

Authors:  J H F Falkenburg; I Jedema
Journal:  Mol Oncol       Date:  2015-10-24       Impact factor: 6.603

3.  Durable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?

Authors:  Cornelis A M van Bergen; Elisabeth M E Verdegaal; M Wilhelmina Honders; Conny Hoogstraten; A Q M Jeanne Steijn-van Tol; Linda de Quartel; Joan de Jong; Maaike Meyering; J H Frederik Falkenburg; Marieke Griffioen; Susanne Osanto
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 4.  Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets.

Authors:  Marieke Griffioen; Cornelis A M van Bergen; J H Frederik Falkenburg
Journal:  Front Immunol       Date:  2016-03-15       Impact factor: 7.561

5.  Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction.

Authors:  Peter van Balen; Boris van der Zouwen; Alwine B Kruisselbrink; Matthijs Eefting; Karoly Szuhai; Ekaterina S Jordanova; J H F Falkenburg; Inge Jedema
Journal:  Front Immunol       Date:  2018-02-27       Impact factor: 7.561

6.  Magnitude of Off-Target Allo-HLA Reactivity by Third-Party Donor-Derived Virus-Specific T Cells Is Dictated by HLA-Restriction.

Authors:  Wesley Huisman; Didier A T Leboux; Lieve E van der Maarel; Lois Hageman; Derk Amsen; J H Frederik Falkenburg; Inge Jedema
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.